Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events-5
Conditions: Ischemic Stroke, Acute Interventions: Drug: Tenecteplase; Drug: Best Practice (which may include intravenous Alteplase) Sponsors: Beijing Tiantan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2024 Category: Research Source Type: clinical trials

Treatment of Acute Ischemic StroKe With Intravenous UroKinase Real-world Research: a Multicenter, Prospective Study
Conditions: Acute Ischemic Stroke Interventions: Drug: Urokinase; Drug: Alteplase Sponsors: The First Affiliated Hospital of Zhengzhou University; Techpool Bio-Pharma Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 8, 2024 Category: Research Source Type: clinical trials

Alteplase Through an Indwelling Pleural Catheter for the Management of Symptomatic Septated Malignant Pleural Effusion
Conditions: Hematopoietic and Lymphoid Cell Neoplasm; Malignant Solid Neoplasm Interventions: Biological: Alteplase; Drug: Placebo Administration Sponsors: M.D. Anderson Cancer Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 28, 2023 Category: Research Source Type: clinical trials

ALteplase in Patients With LOW NIHSS and Specified Disabling Deficits
Conditions: Thrombosis Interventions: Drug: Alteplase Sponsors: Second Affiliated Hospital, School of Medicine, Zhejiang University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2023 Category: Research Source Type: clinical trials

Tenecteplase Thrombolytic Therapy for Acute Ischemic Stroke in China
Conditions: Ischemic Stroke Interventions: Drug: Tenecteplase; Drug: Alteplase Sponsors: Huashan Hospital; Keshiketeng Banner Traditional Chinese Medicine Mongolian Medicine Hospitalorem Ipsum; Nanshi Hospital of Nanyang; The First Affiliated Hospital of Ningbo University; Jilin Liuhe Hospital; Shenyang Fifth People ' s hospital; Shanghai East Hospita; Shanghai 10th People ' s Hospital; Shanghai Fifth People ' s Hospital; Shanghai Pudong Gongli hospital; Shanghai Neuromedical Center; Shanghai Fourth People ' s Hospital; Shanghai Pudong People ' s Hospital; Shanghai Putuo Liqun Hospital; Shenyang Fushun general hospital of ...
Source: ClinicalTrials.gov - October 12, 2023 Category: Research Source Type: clinical trials

Predictors of the Unfavourable Outcomes in Acute Ischemic Stroke Patients Treated With Alteplase, a Multi-centre Prospective Study
Conditions:   Ischemic Stroke;   Alteplase Adverse Reaction Intervention:   Drug: Alteplase Sponsor:   Kafrelsheikh University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 28, 2023 Category: Research Source Type: clinical trials

Predictors of AIS Unfavorable Outcomes
Conditions: Ischemic Stroke; Alteplase Adverse Reaction Interventions: Drug: Alteplase Sponsors: Kafrelsheikh University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 28, 2023 Category: Research Source Type: clinical trials

Predictors of the Unfavourable Outcomes in Acute Ischemic Stroke Patients Treated With Alteplase, a Multi-centre Prospective Study
Conditions: Ischemic Stroke; Alteplase Adverse Reaction Interventions: Drug: Alteplase Sponsors: Kafrelsheikh University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 28, 2023 Category: Research Source Type: clinical trials

Outcomes After Intravenous Alteplase / Tenecteplase With or Without Shuxuetong Injection in Routine Clinical Practice
Condition:   Ischemic Stroke, Acute Intervention:   Drug: Shuxuetong Injection Sponsor:   Dongzhimen Hospital, Beijing Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 30, 2023 Category: Research Source Type: clinical trials